LV: Clinical & Commercial Manufacturing of Lentiviral Vectors
Analytical characterization of full, intermediate, and empty AAV capsids
19th February 2024
An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity
July 13 2024
LV: Analytics for Lentiviral Vectors
A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes
June 2023
ALS meets RNAi
April 2005
AAV: Addressing AAV Manufacturing Challenges
Significant Improvements In Total Lentiviral Titer And Quality Seen By Implementing Process C, A Perfusion-Based System
Preliminary Results of the year ended 31 December 2023
29 April 2024
Preliminary results for the year ended 31 December 2023
29 April 2024
42nd Annual J.P. Morgan Healthcare conference presentation
10 January 2024
42nd Annual J.P. Morgan Healthcare conference presentation
10 January 2024
